Details

Autor(en) / Beteiligte

• de Melo Mendes, Viviane
• Tempone, Andre Gustavo
• Treiger Borborema, Samanta Etel

Titel

Antileishmanial activity of H1-antihistamine drugs and cellular alterations in Leishmania (L.) infantum

Ist Teil von

• Acta tropica, 2019-07, Vol.195, p.6-14

Ort / Verlag

Netherlands: Elsevier B.V

Erscheinungsjahr

2019

Quelle

Alma/SFX Local Collection

Beschreibungen/Notizen

• •Cinnarizine, cyproheptadine, meclizine showed in vitro activity against L. infantum.•They disorganized the intracellular content and detached the nuclear membrane.•They altered the mitochondrial membrane potential of promastigotes.•They induced death in L. infantum affecting the mitochondrion function. Leishmaniases are infectious diseases caused by protozoan parasites Leishmania and transmitted by sand flies. Drug repurposing is a therapeutic approach that has shown satisfactory results in their treatment. Analyses of antihistaminic drugs have revealed their in vitro and in vivo activity against trypanosomatids. In this way, this study evaluated the antileishmanial activity of H1-antihistamines and identified the cellular alterations in Leishmania (L.) infantum. Cinnarizine, cyproheptadine, and meclizine showed activity against promastigotes with 50% inhibitory concentration (IC50) values between 10–29 μM. These drugs also demonstrated activity and selectivity against intracellular amastigotes, with IC50 values between 20–35 μM. Fexofenadine and cetirizine lacked antileishmanial activity against both forms. Mammalian cytotoxicity studies revealed 50% cytotoxic concentration values between 52 - >200 μM. These drugs depolarized the mitochondria membrane of parasites and caused morphological alterations, including mitochondrial damage, disorganization of the intracellular content, and nuclear membrane detachment. In conclusion, the L. infantum death may be ascribed by the subcellular alterations followed by a pronounced decrease in the mitochondrial membrane potential, indicating dysfunction in the respiratory chain upon H1-antihistamine treatment. These H1-antihistamines could be used to explore new routes of cellular death in the parasite and the determination of the targets at a molecular level, would contribute to understanding the potential of these drugs as antileishmanial.